OPKO Health Net Profit Margin 2010-2024 | OPK

OPKO Health net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
OPKO Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-09-30 $0.71B $-0.13B -18.68%
2024-06-30 $0.72B $-0.24B -33.75%
2024-03-31 $0.80B $-0.25B -31.50%
2023-12-31 $0.86B $-0.19B -21.76%
2023-09-30 $0.87B $-0.21B -23.88%
2023-06-30 $0.87B $-0.21B -24.08%
2023-03-31 $0.91B $-0.29B -31.87%
2022-12-31 $1.00B $-0.33B -32.67%
2022-09-30 $1.22B $-0.32B -25.98%
2022-06-30 $1.43B $-0.20B -14.17%
2022-03-31 $1.56B $-0.12B -7.45%
2021-12-31 $1.77B $-0.03B -1.69%
2021-09-30 $1.87B $0.08B 4.07%
2021-06-30 $1.91B $0.07B 3.72%
2021-03-31 $1.77B $0.12B 6.84%
2020-12-31 $1.44B $0.03B 2.16%
2020-09-30 $1.16B $-0.11B -9.71%
2020-06-30 $0.97B $-0.20B -20.62%
2020-03-31 $0.89B $-0.29B -32.92%
2019-12-31 $0.90B $-0.32B -34.96%
2019-09-30 $0.90B $-0.28B -31.03%
2019-06-30 $0.92B $-0.25B -26.63%
2019-03-31 $0.96B $-0.19B -19.94%
2018-12-31 $0.99B $-0.15B -15.44%
2018-09-30 $0.93B $-0.30B -31.72%
2018-06-30 $0.93B $-0.30B -32.72%
2018-03-31 $0.96B $-0.31B -32.88%
2017-12-31 $0.97B $-0.31B -31.68%
2017-09-30 $0.98B $-0.13B -12.81%
2017-06-30 $1.03B $-0.10B -10.12%
2017-03-31 $1.09B $-0.07B -6.50%
2016-12-31 $1.12B $-0.05B -4.30%
2016-09-30 $1.22B $-0.01B -0.74%
2016-06-30 $1.07B $0.13B 12.56%
2016-03-31 $0.75B $0.08B 9.97%
2015-12-31 $0.49B $-0.03B -6.11%
2015-09-30 $0.24B $-0.09B -35.27%
2015-06-30 $0.12B $-0.26B -222.03%
2015-03-31 $0.10B $-0.24B -244.00%
2014-12-31 $0.09B $-0.17B -186.96%
2014-09-30 $0.09B $-0.14B -156.32%
2014-06-30 $0.09B $-0.15B -167.05%
2014-03-31 $0.09B $-0.13B -142.05%
2013-12-31 $0.10B $-0.12B -118.56%
2013-09-30 $0.09B $-0.10B -107.61%
2013-06-30 $0.08B $-0.05B -59.04%
2013-03-31 $0.07B $-0.06B -82.61%
2012-12-31 $0.05B $-0.03B -65.96%
2012-09-30 $0.04B $-0.01B -32.43%
2012-06-30 $0.03B $-0.01B -34.38%
2012-03-31 $0.03B $-0.01B -20.00%
2011-12-31 $0.03B $-0.00B -10.71%
2011-09-30 $0.03B $-0.02B -75.86%
2011-06-30 $0.03B $-0.02B -75.00%
2011-03-31 $0.03B $-0.02B -81.48%
2010-12-31 $0.03B $-0.02B -75.00%
2010-09-30 $0.02B $-0.03B -157.89%
2010-06-30 $0.02B $-0.03B -213.33%
2010-03-31 $0.01B $-0.03B -310.00%
2009-12-31 $0.00B $-0.04B -875.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.003B $0.864B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $198.456B 24.21
Intuitive Surgical (ISRG) United States $187.692B 98.13
Edwards Lifesciences (EW) United States $43.787B 27.81
Alcon (ALC) Switzerland $41.802B 27.97
IQVIA Holdings (IQV) United States $35.837B 19.75
IDEXX Laboratories (IDXX) United States $33.798B 39.80
DexCom (DXCM) United States $30.466B 45.88
Waters (WAT) United States $22.025B 32.57
STERIS (STE) Ireland $20.243B 23.31
SONOVA HOLDING (SONVY) Switzerland $19.510B 0.00
Hologic (HOLX) United States $16.401B 17.71
Fresenius Medical Care AG KGaA (FMS) Germany $13.327B 13.68
Sysmex ADR (SSMXY) Japan $11.544B 36.20
Globus Medical (GMED) United States $11.257B 28.51
Penumbra (PEN) United States $9.141B 89.54
Masimo (MASI) United States $9.026B 43.68
Glaukos (GKOS) United States $8.244B 0.00
Teleflex (TFX) United States $8.223B 13.11
Integer Holdings (ITGR) United States $4.481B 25.40
PROCEPT BioRobotics (PRCT) United States $4.225B 0.00
Veracyte (VCYT) United States $3.100B 93.02
Inari Medical (NARI) United States $3.040B 0.00
LivaNova (LIVN) United Kingdom $2.482B 14.33
Tandem Diabetes Care (TNDM) United States $2.421B 0.00
Nihon Kohden (NHNKY) Japan $2.302B 17.49
Elekta AB (EKTAY) Sweden $2.110B 18.97
TransMedics (TMDX) United States $1.990B 63.06
Integra LifeSciences Holdings (IART) United States $1.734B 9.06
RxSight (RXST) United States $1.363B 0.00
Alphatec Holdings (ATEC) United States $1.288B 0.00
Artivion (AORT) United States $1.198B 79.42
Pulse Biosciences (PLSE) United States $1.086B 0.00
Paragon 28 (FNA) United States $0.858B 0.00
AxoGen (AXGN) United States $0.726B 0.00
Mesa Laboratories (MLAB) United States $0.717B 16.91
AVANOS MEDICAL, INC (AVNS) United States $0.716B 12.17
IRadimed (IRMD) United States $0.698B 37.73
ORTHOFIX MEDICAL INC (OFIX) United States $0.669B 0.00
SiBone (SIBN) United States $0.575B 0.00
OrthoPediatrics (KIDS) United States $0.547B 0.00
Semler Scientific (SMLR) United States $0.521B 27.43
Pacific Biosciences Of California (PACB) United States $0.490B 0.00
Treace Medical Concepts (TMCI) United States $0.429B 0.00
ClearPoint Neuro (CLPT) United States $0.427B 0.00
Tactile Systems Technology (TCMD) United States $0.413B 22.38
Delcath Systems (DCTH) United States $0.380B 0.00
AngioDynamics (ANGO) United States $0.368B 0.00
NeuroPace (NPCE) United States $0.324B 0.00
CVRx (CVRX) United States $0.310B 0.00
Inogen (INGN) United States $0.217B 0.00
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Anteris Technologies Global (AVR) Australia $0.201B 0.00
Accuray (ARAY) United States $0.180B 0.00
Sight Sciences (SGHT) United States $0.179B 0.00
KORU Medical Systems (KRMD) United States $0.178B 0.00
Nevro (NVRO) United States $0.139B 0.00
Atossa Genetics (ATOS) United States $0.123B 0.00
Sensus Healthcare (SRTS) United States $0.118B 12.58
LENSAR (LNSR) United States $0.101B 0.00
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
EDAP TMS S.A (EDAP) France $0.081B 0.00
Vicarious Surgical (RBOT) United States $0.077B 0.00
908 Devices (MASS) United States $0.074B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
WORK Medical Technology Group (WOK) China $0.067B 0.00
Hyperfine (HYPR) United States $0.064B 0.00
Covalon Technologies (CVALF) Canada $0.062B 0.00
Spectral AI (MDAI) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Neuronetics (STIM) United States $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.039B 0.00
Precision Optics (POCI) United States $0.031B 0.00
NexGel (NXGL) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.030B 0.00
Accelerate Diagnostics (AXDX) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.027B 0.00
Biosig Technologies (BSGM) United States $0.022B 0.00
Microbot Medical (MBOT) United States $0.020B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
Ekso Bionics Holdings (EKSO) United States $0.013B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.013B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
QT Imaging Holdings (QTI) United States $0.009B 0.00
PAVmed (PAVM) United States $0.007B 0.00
Baird Medical Investment Holdings (BDMD) $0.007B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00